FIS

FCPM III Services Portfolio holdings

AUM $369M
This Quarter Return
+14.54%
1 Year Return
-29.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$592M
AUM Growth
+$592M
Cap. Flow
-$6.54M
Cap. Flow %
-1.1%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
2
Reduced
3
Closed
–

Top Buys

1
ATXS icon
Astria Therapeutics
ATXS
$25.7M
2
BCYC
Bicycle Therapeutics
BCYC
$15.6M
3
ENGN icon
enGene Holdings
ENGN
$6.35M

Top Sells

1
NAMS icon
NewAmsterdam Pharma
NAMS
$31.7M
2
DYN icon
Dyne Therapeutics
DYN
$11.6M
3
REPL icon
Replimune Group
REPL
$10.8M

Sector Composition

1 Healthcare 99.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$2.71B
$272M 45.98%
10,597,181
-1,234,280
-10% -$31.7M
DYN icon
2
Dyne Therapeutics
DYN
$1.92B
$129M 21.73%
5,462,846
-491,223
-8% -$11.6M
ENGN icon
3
enGene Holdings
ENGN
$236M
$64.1M 10.81%
9,632,561
+954,610
+11% +$6.35M
BCYC
4
Bicycle Therapeutics
BCYC
$511M
$48.3M 8.16%
3,452,330
+1,112,369
+48% +$15.6M
REPL icon
5
Replimune Group
REPL
$422M
$48.1M 8.12%
3,970,668
-895,781
-18% -$10.8M
ATXS icon
6
Astria Therapeutics
ATXS
$349M
$25.7M 4.34%
+2,872,537
New +$25.7M
ACHL
7
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$2.75M 0.46%
2,390,050
– –
ENGNW icon
8
enGene Holdings Inc. Warrants
ENGNW
$7.08M
$2.43M 0.41%
2,878,148
– –